–
Статьи в журналах
-
- 2019 Doxorubicin-loaded PLGA nanoparticles for the chemotherapy of glioblastoma: Towards the pharmaceutical development
- Maksimenko O.O., Malinovskaya J., Shipulo E., Osipova N.S., Razzhivina V.A., Arantseva D., Yarovaya O., Mostovaya U., Khalansky A., Fedoseeva V.V., Alekseeva A.I., Vanchugova L., Gorshkova M.Y., Kovalenko E.I., Balabanyan V., Melnikov P., Baklaushev V., Chekhonin V., Kreuter J., Gelperina S.
- в журнале International Journal of Pharmaceutics, издательство Elsevier BV (Netherlands), том 572, с. e118733 DOI
-
- 2019 Toxicological study of doxorubicin-loaded PLGA nanoparticles for the treatment of glioblastoma
- Pereverzeva E., Treschalin I., Treschalin M., Arantseva D., Ermolenko Yu, Kumskova N., Maksimenko O., Balabanyan V., Kreuter J., Gelperina S.
- в журнале International Journal of Pharmaceutics, издательство Elsevier BV (Netherlands), том 554, с. 161-178 DOI
-
- 2014 The Atropomer Composition of Iopromide as an Indicator for Assessment of the Quality of its Substance and Medincal Formulations
- Glushkov R.G., Goizman M.S., Arantseva D.A., Demidova N.N., Kulaeva E.K., Zagudailova M.B., Dmitriev D.E., Trifilenkov A.S., Korlyukov A.A., Arkhipov D.E., Suponitskii K.Yu, Shimanovskii N.L., Zaitsev S.A., Degterev E.V.
- в журнале Pharmaceutical Chemistry Journal, издательство Kluwer Academic/Plenum Publishers (United States), том 48, № 3, с. 186-195 DOI